NIH-funded research NIH-funded research

A new method to personalize treatment for kidney transplant rejection

Official title: Bioinformatics pipeline for personalized diagnostics of transplant rejection

Funded at Datirium, LLC · NIH-11069619 · Data updated 2026-11-12

This study is looking at how certain genes behave in kidney transplant patients to help doctors figure out who might be at risk of rejection, so they can give the right treatments to keep the transplant healthy and working well.

More Transplant research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionDatirium, LLC
NIH-funded
Lab location1 site (Cincinnati, UNITED STATES)
Project startJanuary 6, 2025
Project endDecember 31, 2026
Funding year2025
Award (this year)$306,500
NIH project number1R41AI189162-01
Project IDNIH-11069619 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have received a kidney transplant and are at risk of transplant rejection.

Less likely to help

Patients who have not undergone kidney transplantation or those who are not at risk of rejection may not benefit from this research.

What this research studies

This research focuses on developing a bioinformatics pipeline that analyzes gene expression in kidney transplant patients to better understand and diagnose transplant rejection. By examining specific immune cell responses, particularly CD8 T cells, the project aims to identify which patients are at risk of rejection and tailor anti-rejection therapies accordingly. This personalized approach could lead to more effective management of transplant patients, potentially reducing the incidence of graft loss. The methodology involves advanced single-cell RNA sequencing and VDJ analysis of kidney biopsies and urine samples.

Why it matters

Potential benefit: If successful, this research could significantly improve the success rates of kidney transplants by enabling personalized anti-rejection therapies.

How similar studies have gone: Previous research has shown promise in using bioinformatics and gene expression analysis for personalized medicine, indicating potential success for this approach.

Where this research is happening

  • Datirium, LLC
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Barski, Artem — Datirium, LLC
  • Study coordinator: Barski, Artem

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.